Study Shows New Option for Kids With Tough-to-Treat Leukemia

<p>WEDNESDAY, Apr 11 (HealthDay News) — Additional <span>chemotherapy</span>
may a improved choice than <span>bone pith transplant</span> for some children with<span>acute lymphoblastic leukemia</span> who don’t respond to an initial intense
regimen of chemotherapy called “<span>induction therapy</span>,” a new investigate says.</p>
<p> Acute lymphoblastic leukemia, or ALL, is a cancer of a blood and
bone marrow.</p>
<p>According to investigate co-author Dr. <span>Ching-Hon Pui</span>, disaster to improve
after initiation therapy is rare, function in only 2 percent to 3 percent
of children with ALL. But when it does happen, these children’s risk for a
bad outcome rises considerably, so they mostly afterwards turn possibilities for a
bone pith transplant. </p>
<p>However, a new investigate suggests that that choice might not always be the
only one.</p>
<p>“Some patients and ...